Abstract:
This paper reviews the literature on health status and quality of life (QOL) in patients with movement disorders with a focus on the following diseases: Parkinson’s disease, atypical Parkinsonism (multiple system atrophy, progressive supranuclear palsy, dementia with Lewy bodies), Huntington’s disease and Restless Legs Syndrome.
Several disease-specific instruments are currently available for the different movement disorders. For Parkinson’s disease, 8 different scales have been developed and almost all focus primarily on the health status of the patient. Parkinson’s disease is associated with reduced health status, including motor and non-motor physical complications of the disease, emotional well-being and social functioning. Although the impact is greater in advanced stages of Parkinson’s disease, there is no close relationship between disease duration and impact on health status. Occurrence and severity of depression, however, correlates notably with health status scores, and a number of studies have found depression to be one of the primary determinants of poor health status.
In atypical Parkinsonism specific, validated instruments exist for multiple system atrophy and progressive supranuclear palsy. A considerable reduction in health status scores was reported for all patients suffering from atypical Parkinsonism and health status appeared to be impaired more severely than in Parkinson’s disease after the same disease duration. In dementia with Lewy bodies, health status is affected more severely than in matched patients with Alzheimer’s disease.
Condition-specific instruments have been developed and validated for health status assessment in both patients with Huntington’s disease and their caregivers. The impact of Huntington’s disease on quality of life is considerable and not only limited to affected patients but also affects their families, particularly family members who may be carrying the gene, as well as caregivers of patients. In restless legs syndrome, several disease-specific instruments are currently available and have been used in clinical trails. Health status is markedly reduced in patients with restless legs syndrome and is affected to a similar extent as in patients with Parkinson’s disease.
Although the evaluation of alternative outcomes in movement disorders has emerged in recent years, many questions have not been addressed and thus require further research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 15D:
-
15D questionnaire
- EQ-5D:
-
EuroQOL
- EQ-VAS:
-
EuroQOL visual analogue scale
- HrQOL:
-
Health-related quality of life
- HUI:
-
Health Utility Index
- MSA:
-
multiple system atrophy
- NHP:
-
Nottingham Health Profile
- PDQ-39:
-
Parkinson’s disease questionnaire 39-item version
- PDQ-8:
-
Parkinson’s Disease Questionnaire 8-item version
- PDQL:
-
Parkinson’s Disease Quality of Life questionnaire
- PDQUALIF:
-
Parkinson’s Disease Quality of Life
- PDSI:
-
Parkinson’s Disease Symptom Inventory
- PIMS:
-
Parkinson’s Impact Scale
- PLQ:
-
Parkinson Lebensqualität
- PSP:
-
Progressive supranuclear palsy
- QLI:
-
Quality of Life Index
- QLS(M)-MD/QLS(M)-DBS:
-
Quality of life with DBS
- QOL:
-
quality of life
- RLS-QLI:
-
Restless legs syndrome quality of life instrument
- RLS-QOL:
-
Restless legs syndrome quality of life
- SCOOPA-PS/-AUT/-SLEEP/-COG:
-
Scales for Outcomes in Parkinson’s disease
- SEIQOL-DW:
-
Schedule for the Evaluation of Individual Quality of Life - Direct Weighting
- SF 36:
-
Short Form Health Survey
- SIP:
-
Sickness Impact Profile
- UPDRS:
-
Unified Parkinson’s Disease Rating Scale
- WHOQOL100-BREF:
-
World Health Organization Quality of Life assessment instrument
References
Abele M, Klockgether T. (2007). Mov Disord. 22: 348–352.
Abetz L, Allen R, Follet A, Washburn T, Earley C, Kirsch J, Knight H. (2004). Clin Ther. 26: 925–935.
Abetz L, Arbuckle R, Allen RP, Mavraki E, Kirsch J. (2005). Health Qual Life Outcomes. 3: 79–90.
Atkinson MJ, Allen RP, DuChane J, Murray C, Kushida C, Roth T. (2004). Qual Life Res. 13: 679–693.
Aubeeluck A, Buchanan H. (2007). Clin Genet. 71: 434–445.
Baas HK, Schueler P. (2001). Eur Neurol 46 Suppl. 1: 18–23.
Benrud-Larson LM, Sandroni P, Schrag A, Low PA. (2005). Mov Disord. 20: 951–957.
Boström F, Jönsson L, Minthon L, Londos E. (2007). Alzheimer Dis Assoc Disord. 21: 150–154.
Camfield L, Ben-Shlomo Y, Warner TT. (2002). Mov Disord 17: 838–841.
Carod-Artal FJ, Vargas AP, Martinez-Martin P. (2007). Mov Disord. 22: 1408–1415.
Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F. (2005). Mov Disord. 20: 224–230.
Den Oudsten BL, Van Heck GL, De Vries J. (2007). Mov Disord. 22: 1528–1537.
Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J. (2006). N Engl J Med. 355: 896–908.
Elstner K, Selai CE, Trimble MR, Robertson MM. (2001). Acta Psychiatr Scand 103: 52–59.
Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, et al. (2007). Mov Disord 22: 1689–1707.
Evers-Kiebooms G, Decruyenaere M. (1998). Patient Educ Couns. 35: 15–26.
Gerhard R, Bosse A, Uzun D, Orth M, Kotterba S. (2005). Med Klin (Munich). 100: 704–709.
Gerschlager W, Schrag A, Brown P. (2002). Mov Disord. 17: 1064–1067.
Global Parkinson’s Disease Survey Steering Committee. (2002). Mov Disord. 17: 60–67.
Gomez-Esteban JC, Zarranz JJ, Lezcano E, Tijero B, Luna A, Velasco F, Rouco I, Garamendi I. (2007). Eur Neurol. 57: 161–165.
Gronchi-Perrin A, Viollier S, Ghika J, Combremont P, Villemure JG, Bogousslavsky J, Burkhard PR, Vingerhoets F. (2006). Mov Disord 21: 1465–1468.
Happe S, Reese JP, Stiasny-Kolster K, Peglau I, Mayer G, Klotsche J, Giani G, Geraedts M, Trenkwalder C, Dodel R. (2008). Sleep Med doi: 10.1016/j.sleep.2008.01.002.
Helder DI, Kaptein AA, Van Kempen GM, Weinman J, Van Houwelingen HC, Roos RA. (2002). Br J Health Psychol. 7: 449–462.
Ho AK, Robbins AO, Walters SJ, Kaptoge S, Sahakian BJ, Barker RA. (2004). Mov Disord. 19: 1341–1348.
Hobson P, Holden A, Meara J. (1999). Age Ageing. 28: 341–346.
Jain S, Dawson J, Quinn NP, Playford ED. (2004). Mov Disord. 19: 1360–1364.
Karlsen KH, Larsen JP, Tandberg E, Maeland JG. (1999). J Neurol Neurosurg Psychiatry. 66: 431–435.
Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G. (2006). Mov Disord 21 Suppl. 14: S290–S304.
Kohnen R, Benes H, Kurella B. (2002). Mov Disord. 17: P743.
Koller W, Lees A, Doder M, Hely M. (2001). Mov Disord. 16: 858–866.
König HH, Bernert S, Angermeyer MC. (2005). Gesundheitswesen 67: 173–182.
Kuopio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK. (2000). Mov Disord. 15: 216–223.
Kushida C, Martin M, Nikam P, Blaisdell B, Wallenstein G, Ferini-Strambi L, Ware JE Jr. (2007). Qual Life Res. 16: 617–624.
Kushida CA, Allen RP, Atkinson MJ. (2004). Sleep Med. 5: 485–488.
Lopez-Bastida J, Perestelo-Perez L, Monton-Alvarez F, Serrano-Aguilar P. (2008). Mov Disord. 23: 212–217.
Lorenz D, Schwieger D, Moises H, Deuschl G. (2006). Mov Disord. 21: 1114–1118.
Marinus J, Ramaker C, van Hilten JJ, Stiggelbout AM. (2002). J Neurol Neurosurg Psychiatry. 72: 241–248.
McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, et al. (2005). Neurology 65: 1863–1872.
Moore AP, Lloyd A, Scott DA, Connolly M, Dixon S. (2004). Value in Health. 7: 791.
Noyes K, Dick AW, Holloway RG. (2006). Value Health 9: 28–38.
O’Connor EJ, McCabe MP, Firth L. (2008). J Sex Marital Ther. 34: 115–132.
Reese J, Stiasny-Kolster K, Oertel W, Dodel R. (2007).
Reuther M, Spottke EA, Klotsche J, Riedel O, Peter H, Berger K, Athen O, Kohne-Volland R, Dodel RC. (2007). Parkinsonism Relat Disord. 13: 108–114.
Riedemann C, Zerr I, Kropp S, Otto A, Poser S, Herrmann C. (1999). Z Psychosom Med Psychother. 45: 128–141.
Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. (2000). Neurology. 54: 1064–1068.
Saletu M, Anderer P, Hogl B, Saletu-Zyhlarz G, Kunz A, Poewe W, Saletu B. (2003). J Neural Transm. 110: 611–626.
Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Köllensperger M, Scherfler C, Quinn N, Pellecchia MT, Barone P, Del Sorbo F, Albanese A, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Nilsson CF, Widner H, Lindvall O, Giladi N, Gurevich T, Daniels C, Deuschl G, Coelho M, Sampaio C, Abele M, Klockgether T, Schimke N, Eggert KM, Oertel W, Djaldetti R, Colosimo C, Meco G, Poewe W, GK; W, Group. EM-S. (2006). Mov Disord. 21: 809–815.
Schrag A. Jahanshahi M, Quinn N. (2000). J Neurol Neurosurg Psychiatry. 69: 308–312.
Schrag A, Selai C, Davis J, Lees AJ, Jahanshahi M, Quinn N. (2003). Mov Disord. 18: 1464–1469.
Schrag A, Selai C, Mathias C, Low P, Hobart J, Brady N, Quinn NP. (2007). Mov Disord. 22: 2332–2338.
Schrag A, Selai C, Quinn N, Lees A, Litvan I, Lang A, Poon Y, Bower J, Burn D, Hobart J. (2006). Neurology. 67: 39–44.
Slawek J, Derejko M, Lass P. (2005). Parkinsonism Relat Disord. 11: 465–468.
Slawek J, Friedman A, Potulska A, Krystkowiak P, Gervais C, Banach M, Ochudlo S, Budrewicz S, Reclawowicz D, Rynkowski M, Opala G. (2007). Funct Neurol. 22: 95–100.
Storch EA, Merlo LJ, Lack C, Milsom VA, Geffken GR, Goodman WK, Murphy TK. (2007). J Clin Child Adolesc Psychol. 36: 217–227.
Sutcliffe RP, Maguire DD, Muiesan P, Dhawan A, Mieli-Vergani G, O’Grady JG, Rela M, Heaton ND. (2003). Transplantation. 75: 1003–1006.
von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Dodel R. (2005). Eur Neuropsychopharmacol 15: 473–490.
Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. (2004). J Am Geriatr Soc. 52: 784–788.
Zaccai J, McCracken C, Brayne C. (2005). Age Ageing. 34: 561–566.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Dodel, R., Schrag, A. (2010). Health-Related Quality of Life in Movement Disorders. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_234
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_234
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine